Search research articles
Contact Us
Filters
Showing results (41-50 of 176) with videos related to
Page
of 18
Sort By:
Pharmacology & Therapeutics
|
June 4, 2009
Therapeutic regulation of apoB100 metabolism in insulin resistance in vivo
Gerald F Watts, Esther M M Ooi, Dick C Chan
Best Practice & Research. Clinical Endocrinology & Metabolism
|
May 21, 2014
The metabolic and pharmacologic bases for treating atherogenic dyslipidaemia
Dick C Chan, P Hugh R Barrett, Gerald F Watts
Annals of Medicine
|
April 20, 2011
Apolipoprotein A-II: evaluating its significance in dyslipidaemia, insulin resistance, and atherosclerosis
Dick C Chan, Theodore W K Ng, Gerald F Watts
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
August 3, 2004
Dyslipidemia in visceral obesity: mechanisms, implications, and therapy
Dick C Chan, Hugh P R Barrett, Gerald F Watts
The Clinical Biochemist. Reviews
|
June 3, 2008
Lipoprotein kinetics in the metabolic syndrome: pathophysiological and therapeutic lessons from stable isotope studies
Dick C Chan, P Hugh R Barrett, Gerald F Watts
Cardiovascular Research
|
September 10, 2025
A new PCSK-9 monoclonal antibody for lowering LDL-cholesterol and lipoprotein(a) in Chinese patients with familial hypercholesterolaemia
Seyed Saeed Tamehri Zadeh, Dick C Chan, Gerald F Watts
Current Opinion in Lipidology
|
November 3, 2016
Recent explanatory trials of the mode of action of drug therapies on lipoprotein metabolism
Dick C Chan, P Hugh R Barrett, Gerald F Watts
Nature Reviews. Cardiology
|
September 25, 2013
Demystifying the management of hypertriglyceridaemia
Gerald F Watts, Esther M M Ooi, Dick C Chan
Nature Reviews. Cardiology
|
January 8, 2014
More data needed on curcuminoids in hypertriglyceridaemia
Gerald F Watts, Esther M M Ooi, Dick C Chan
Frontiers in Genetics
|
May 16, 2022
Familial Hypercholesterolemia and Elevated Lipoprotein(a): Cascade Testing and Other Implications for Contextual Models of Care
Wann Jia Loh, Dick C Chan, Pedro Mata, et al.
Page
of 18
Search research articles
Search
Showing results (41-50 of 176) with videos related to
Sort By:
Page
of 18
Pharmacology & Therapeutics
|
June 4, 2009
Therapeutic regulation of apoB100 metabolism in insulin resistance in vivo
Gerald F Watts, Esther M M Ooi, Dick C Chan
Best Practice & Research. Clinical Endocrinology & Metabolism
|
May 21, 2014
The metabolic and pharmacologic bases for treating atherogenic dyslipidaemia
Dick C Chan, P Hugh R Barrett, Gerald F Watts
Annals of Medicine
|
April 20, 2011
Apolipoprotein A-II: evaluating its significance in dyslipidaemia, insulin resistance, and atherosclerosis
Dick C Chan, Theodore W K Ng, Gerald F Watts
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
August 3, 2004
Dyslipidemia in visceral obesity: mechanisms, implications, and therapy
Dick C Chan, Hugh P R Barrett, Gerald F Watts
The Clinical Biochemist. Reviews
|
June 3, 2008
Lipoprotein kinetics in the metabolic syndrome: pathophysiological and therapeutic lessons from stable isotope studies
Dick C Chan, P Hugh R Barrett, Gerald F Watts
Cardiovascular Research
|
September 10, 2025
A new PCSK-9 monoclonal antibody for lowering LDL-cholesterol and lipoprotein(a) in Chinese patients with familial hypercholesterolaemia
Seyed Saeed Tamehri Zadeh, Dick C Chan, Gerald F Watts
Current Opinion in Lipidology
|
November 3, 2016
Recent explanatory trials of the mode of action of drug therapies on lipoprotein metabolism
Dick C Chan, P Hugh R Barrett, Gerald F Watts
Nature Reviews. Cardiology
|
September 25, 2013
Demystifying the management of hypertriglyceridaemia
Gerald F Watts, Esther M M Ooi, Dick C Chan
Nature Reviews. Cardiology
|
January 8, 2014
More data needed on curcuminoids in hypertriglyceridaemia
Gerald F Watts, Esther M M Ooi, Dick C Chan
Frontiers in Genetics
|
May 16, 2022
Familial Hypercholesterolemia and Elevated Lipoprotein(a): Cascade Testing and Other Implications for Contextual Models of Care
Wann Jia Loh, Dick C Chan, Pedro Mata, et al.
Page
of 18